KKR Buys Minority Stake in Life Sciences Investor Catalio Capital
Wall Street Journal
KKR has acquired a minority stake in Catalio Capital Management, a firm that manages venture-capital and other medical-investment funds, adding to a trend of private-equity firms moving upstream in life sciences through deals with earlier-stage investors.